Evidence map›Paper›PMID 30830581›Full record

ArticleTransgenic research2019

Benefits of genome-edited crops: expert opinion.

Rim Lassoued, Diego Maximiliano Macall, Hayley Hesseln, Peter W B Phillips, Stuart J Smyth

Abstract read
In one paragraph

Article in Transgenic research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Unlocking the future of crop improvement with crop wild relatives.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2026
    Review
  4. Review
  5. Review
  6. From Blog to lab: testing messages to shift public opinion on gene editing.Frontiers in bioengineering and biotechnology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. HarnessingFrontiers in microbiology · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. CRISPR-Cas technology a new era in genomic engineering.Biotechnology reports (Amsterdam, Netherlands) · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rim LassouedDepartment of Agricultural and Resource Economics, University of Saskatchewan, 51 Campus Drive, Saskatoon, SK, S7N 5A8, Canada. rim.lassoued@usask.ca.ORCID 0000-0002-7435-9935
Diego Maximiliano MacallDepartment of Agricultural and Resource Economics, University of Saskatchewan, 51 Campus Drive, Saskatoon, SK, S7N 5A8, Canada.ORCID 0000-0002-9436-8740
Hayley HesselnDepartment of Agricultural and Resource Economics, University of Saskatchewan, 51 Campus Drive, Saskatoon, SK, S7N 5A8, Canada.ORCID 0000-0002-3155-612X
Peter W B PhillipsThe Johnson Shoyama Graduate School of Public Policy, University of Saskatchewan, 101 Diefenbaker Place, Saskatoon, SK, S7N 5B8, Canada.ORCID 0000-0002-9152-5886
Stuart J SmythDepartment of Agricultural and Resource Economics, University of Saskatchewan, 51 Campus Drive, Saskatoon, SK, S7N 5A8, Canada.ORCID 0000-0003-0837-8617

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Innovation in agriculture is pervasive. However, in spite of the success stories of twentieth century plant breeding, the twenty-first century has ushered in a set of challenges that solutions from the past century are unlikely to address. However, sustained research and the amalgamation of a number of disciplines has resulted in new breeding techniques (NBTs), such as genome editing, which offer the promise of new opportunities to resolve some of the issues. Here we present the results of an expert survey on the added potential benefits of genome-edited crops compared to those developed through genetic modification (GM) and conventional breeding. Overall, survey results reveal a consensus among experts on the enhanced agronomic performance and product quality of genome-edited crops over alternatives. The majority of experts indicated that the regulations for health and safety, followed by export markets, consumers, and the media play a major role in determining where and how NBTs, including genome editing, will be developed and used in agriculture. Further research is needed to gauge expert opinion after the Court of Justice of the European Union ruling establishing that site-specific mutagenic breeding technologies are to be regulated in the same fashion as GM crops, regardless of whether foreign DNA is present in the final variety.

Indexed as

Gene EditingGenetic EngineeringGenome, PlantPlant BreedingCrops, AgriculturalHumansPlants, Genetically ModifiedAgricultural biotechnologyConventional cropsGenetically modified cropsInnovationNew breeding techniquesRegulation

Identifiers

PMID30830581
PMCPMC6440930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.